ArticleBMC infectious diseases2025
Sero-prevalence of hepatitis B virus and associated risk factors among pregnant women attending Demartino hospital, Mogadishu, Somalia.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Article
- Sero-prevalence of hepatitis b virus infection and its associated factors among pregnant women attending antenatal care at public health facilities in Babile district, Eastern Ethiopia.BMC pregnancy and childbirth · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBackground: Hepatitis B virus infection is the most prevalent cause of serious liver infection. During pregnancy, hepatitis B virus has a higher vertical transmission rate that may later impair the physical and cognitive development of a child. The main objective of this study was to investigate the seroprevalence of hepatitis B viral infection and identify the associated factors among pregnant women attending antenatal care at Demartino Hospital.
methodsThis is an institution-based, cross-sectional study that involved pregnant women to ascertain the seroprevalence of HBsAg among them between January and February 2024. Participants were interviewed for data using an interviewer-administered structured questionnaire. Each participant had a venous blood sample of five milliliters taken. Plasma was extracted from the blood samples and subjected to investigation using the advanced quality one-step HBsAg test kit, If the results were positive, additional testing using ELISA was conducted to determine hepatitis seroprevalence. The data were analyzed by SPSS, version 25, and both bivariate and multivariate logistic regression analyses were performed to assess the independent predictors of HBsAg seroprevalence, at a p-value of < 0.05.
resultsThe overall sero-prevalence of HBV among the pregnant women was 13.3%. History of blood transfusion (AOR = 4.271; 95% CI = 1.488-12.254), history of abortion (AOR = 3.822; 95% CI = 2.009-7.271), family history of hepatitis B infection (AOR = 5.104; 95% CI = 1.900-13.713), and history of sharing sharp materials (AOR = 3.427; 95% CI = 1.153-10.186) were found to be independently significantly associated with HBsAg seropositivity.
conclusionIn WHO classification, the seroprevalence rate of HBsAg among pregnant women in this present study was highly endemic. History of abortion, history of blood transfusion, history of shared sharp materials, and family history of hepatitis B infection were risk factors which significantly predict HBsAg seropositivity. The Federal Ministry of Health needs to establish hepatitis B health education campaigns, Screening Programmes, Vaccination Programs, and treatment should be given for those already infected to save their lives and prevent Mother to Child transmission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.